Literature DB >> 36216893

Genetically encoded chemical crosslinking of carbohydrate.

Shanshan Li1, Nanxi Wang1, Bingchen Yu1, Wei Sun1, Lei Wang2.   

Abstract

Protein-carbohydrate interactions play important roles in various biological processes, such as organism development, cancer metastasis, pathogen infection and immune response, but they remain challenging to study and exploit due to their low binding affinity and non-covalent nature. Here we site-specifically engineered covalent linkages between proteins and carbohydrates under biocompatible conditions. We show that sulfonyl fluoride reacts with glycans via a proximity-enabled reactivity, and to harness this a bioreactive unnatural amino acid (SFY) that contains sulfonyl fluoride was genetically encoded into proteins. SFY-incorporated Siglec-7 crosslinked with its sialoglycan ligand specifically in vitro and on the surface of cancer cells. Through irreversible cloaking of sialoglycan at the cancer cell surface, SFY-incorporated Siglec-7 enhanced the killing of cancer cells by natural killer cells. Genetically encoding the chemical crosslinking of proteins to carbohydrates (GECX-sugar) offers a solution to address the low affinity and weak strength of protein-sugar interactions.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 36216893     DOI: 10.1038/s41557-022-01059-z

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.274


  42 in total

Review 1.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

Authors:  Robert G Spiro
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

Review 2.  Carbohydrate-protein interactions in vascular biology.

Authors:  R M Nelson; A Venot; M P Bevilacqua; R J Linhardt; I Stamenkovic
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

Review 3.  Protein glycosylation in cancer.

Authors:  Sean R Stowell; Tongzhong Ju; Richard D Cummings
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

Review 4.  High-affinity anti-glycan antibodies: challenges and strategies.

Authors:  Zinaida Polonskaya; Paul B Savage; M G Finn; Luc Teyton
Journal:  Curr Opin Immunol       Date:  2019-04-28       Impact factor: 7.486

5.  Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics.

Authors:  Qingke Li; Qu Chen; Paul C Klauser; Mengyuan Li; Feng Zheng; Nanxi Wang; Xiaoying Li; Qianbing Zhang; Xuemei Fu; Qian Wang; Yang Xu; Lei Wang
Journal:  Cell       Date:  2020-06-23       Impact factor: 41.582

Review 6.  The sweet and sour of cancer: glycans as novel therapeutic targets.

Authors:  Mark M Fuster; Jeffrey D Esko
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

7.  Adding an unnatural covalent bond to proteins through proximity-enhanced bioreactivity.

Authors:  Zheng Xiang; Haiyan Ren; Ying S Hu; Irene Coin; Jing Wei; Hu Cang; Lei Wang
Journal:  Nat Methods       Date:  2013-08-04       Impact factor: 28.547

Review 8.  Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database.

Authors:  Eric Sterner; Natalie Flanagan; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2016-05-25       Impact factor: 5.100

Review 9.  Glycotherapy: new advances inspire a reemergence of glycans in medicine.

Authors:  Jason E Hudak; Carolyn R Bertozzi
Journal:  Chem Biol       Date:  2013-11-21

10.  Spontaneous and specific chemical cross-linking in live cells to capture and identify protein interactions.

Authors:  Bing Yang; Shibing Tang; Cheng Ma; Shang-Tong Li; Guang-Can Shao; Bobo Dang; William F DeGrado; Meng-Qiu Dong; Peng George Wang; Sheng Ding; Lei Wang
Journal:  Nat Commun       Date:  2017-12-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.